In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes
- PMID: 1087237
- DOI: 10.1002/eji.1830061109
In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes
Abstract
Murine T cells were sensitized in vitro towards fluorescein isothiocyanate (FITC)-conjugated syngeneic spleen cells. The lytic activity of the effector cells generated was restricted to FITC-conjugated, H-2-compatible target cells. 2,4,6-Trinitrophenyl (TNP)-conjugated syngeneic targets were not lysed. A method is described for the in vivo sensitization of murine T cells towards TNP (or FITC)-conjugated syngeneic spleen cells. The procedure is based on the observation that a local graft of hapten-conjugated syngeneic spleen cells results in the development of sensitized prekiller T cells within the draining lymph node (LN). By mere in vitro incubation of such LN cells immunological specific anti-TNP (or anti-FITC)-reactive cytotoxic T lymphocytes (CTL) are generated. The in vitro differentiation of CTL requires 48-72 h; it is dependent on cell proliferation and is abolished by treatment of the LN cells with mitomycin C. Thus there is a separation between the sensitization of CTL precursors (which effectively takes place in vivo) and the phase of cell differentiation into CTL (which effectively takes place only in vitro). Similar to in vitro-sensitized CTL, the specificity of in vivo-sensitized CTL is dictated by the hapten used for the induction of the immune response and is restricted to hapten-conjugated syngeneic target cells.
Similar articles
-
Induction of I region-restricted hapten-specific cytotoxic T lymphocytes.J Immunol. 1977 Oct;119(4):1365-8. J Immunol. 1977. PMID: 302282
-
Helper cell analysis in cytotoxic T lymphocyte responses. I. Activation of specific and cross-reactive helper effects in two hapten-modified self responses.Eur J Immunol. 1980 Dec;10(12):904-7. doi: 10.1002/eji.1830101203. Eur J Immunol. 1980. PMID: 6162647
-
Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.Eur J Immunol. 1981 Sep;11(9):700-4. doi: 10.1002/eji.1830110906. Eur J Immunol. 1981. PMID: 6975212
-
Renaissance for hapten-specific T lymphocytes: implications for basic and applied research.Z Naturforsch C J Biosci. 1992 May-Jun;47(5-6):323-8. Z Naturforsch C J Biosci. 1992. PMID: 1418235 Review.
-
T lymphocyte stimulation by hapten-conjugated macrophages: a model system for the study of immunocompetent cell interactions.Immunol Rev. 1978;40:181-204. doi: 10.1111/j.1600-065x.1978.tb00406.x. Immunol Rev. 1978. PMID: 381166 Review. No abstract available.
Cited by
-
H-2 restriction as a consequence of intentional priming: T cells of fully allogeneic chimeric mice as well as of normal mice respond to foreign antigens in the context of H-2 determinants not encountered on thymic epithelial cells.Proc Natl Acad Sci U S A. 1980 Dec;77(12):7390-4. doi: 10.1073/pnas.77.12.7390. Proc Natl Acad Sci U S A. 1980. PMID: 6261255 Free PMC article.
-
Tolerance, suppression and the fetal allograft.J Mol Med (Berl). 2005 Feb;83(2):88-96. doi: 10.1007/s00109-004-0608-2. Epub 2004 Dec 17. J Mol Med (Berl). 2005. PMID: 15605274 Review.
-
Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.Br J Cancer. 1978 Sep;38(3):365-74. doi: 10.1038/bjc.1978.216. Br J Cancer. 1978. PMID: 81673 Free PMC article.
-
T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia.J Exp Med. 1978 Jan 1;147(1):251-64. doi: 10.1084/jem.147.1.251. J Exp Med. 1978. PMID: 415107 Free PMC article.
-
Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.J Exp Med. 1981 Aug 1;154(2):262-74. doi: 10.1084/jem.154.2.262. J Exp Med. 1981. PMID: 6790656 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources